LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.

Lebelt, Agnieszka / Rutkowski, Robert / Och, Waldemar / Jaczun, Kamil / Dziemiańczyk-Pakieła, Dorota / Milewski, Robert / Mariak, Zenon / Reszeć, Joanna

Advances in medical sciences

2016  Volume 61, Issue 2, Page(s) 237–243

Abstract: Purpose: Gliomas are the most common primary brain tumors. The etiology is still unclear and the progression from low to high-grade gliomas is frequent. The molecular mechanisms are quite established, however the heterogeneity of glioblastomas force the ...

Abstract Purpose: Gliomas are the most common primary brain tumors. The etiology is still unclear and the progression from low to high-grade gliomas is frequent. The molecular mechanisms are quite established, however the heterogeneity of glioblastomas force the scientist to look for the new therapeutic targets. The aim of the study was to evaluate the caspase-3 and survivin expression in correlation with MIB-1 expression in gliomas of various grade to assess the apoptosis in gliomas and to determinate new possible targets for the future therapy.
Material and methods: We identified 131 patients with a histopathological diagnosis of astrocytic tumors (diffuse astrocytoma, anaplastic astrocytoma and glioblastoma). The evaluation of caspase-3, survivin and MIB-1 expression was done using immunohistochemical methods.
Results: Caspase-3 and survivin expression was observed both in low- and high-grade astrocytomas. The differences in expression were the most evident in glioblastoma group. All primary glioblastomas (31 cases) expressed caspase-3. In secondary glioblastoma group only 17 out of 30 specimens were positive for caspase-3. Survivin expression was observed in 80.6% primary glioblastomas and in all examined secondary glioblastomas and the staining was strong and diffuse in all cases. MIB-1 expression was low in diffuse astrocytomas (DA) and ranged between 1 and 5%. In anaplastic astrocytoma group it was ranged between 5 and 10% and the highest percentage of the positive cells was observed in glioblastoma cases and ranged from 10% even to 30%. The most evident MIB-1 expression was observed in the cells surrounding the pathological blood vessels and necrosis.
Conclusions: The high incidence of survivin and caspase-3 expression in diffuse and anaplastic astrocytoma cases may suggest, that the regulation between pro- and antiapoptotic proteins may play an important role in tumor growth and progression. The overexpression of survivin and MIB-1 expression in glioblastoma cases also may confirm the theory about the important role of anti-apoptotic and proliferation processes in glioblastoma progression and as such may be potential therapeutic targets.
MeSH term(s) Aged ; Astrocytoma/metabolism ; Astrocytoma/pathology ; Caspase 3/metabolism ; Female ; Humans ; Inhibitor of Apoptosis Proteins/metabolism ; Male ; Middle Aged ; Neoplasm Grading ; Ubiquitin-Protein Ligases/metabolism
Chemical Substances BIRC5 protein, human ; Inhibitor of Apoptosis Proteins ; MIB1 ligase, human (EC 2.3.2.27) ; Ubiquitin-Protein Ligases (EC 2.3.2.27) ; Caspase 3 (EC 3.4.22.-)
Language English
Publishing date 2016-09
Publishing country Netherlands
Document type Journal Article
ZDB-ID 2273668-2
ISSN 1898-4002 ; 1896-1126
ISSN (online) 1898-4002
ISSN 1896-1126
DOI 10.1016/j.advms.2016.02.001
Shelf mark
Zs.B 953: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top